Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RXRX · against 1,372 other Healthcare companies
Ranked #447 of 1,373 · scores higher than 67% of peers · safety percentile 67
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 60–69, including RXRX · Click a bar to see the companies
Mainly thanks to its current ratio and debt / equity, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | RXRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.07× | 0.24× | 71% | 33% | |
| BetaLower is better · 1,320 reported | 1.07 | 0.53 | 22% | 33% | |
| Current ratioHigher is better · 1,338 reported | 5.03× | 2.62× | 74% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 443 | 138.4B HKD (≈$17.7B) | 68 | 70 | |
| 444 | 35.1B CNY (≈$4.9B) | 68 | 56 | |
| 445 | 177.2B HKD (≈$22.7B) | 68 | 73 | |
| 446 | 204.5B JPY (≈$1.4B) | 68 | 71 | |
| 447 | 2.0B USD | 67 | 24 | |
| 448 | 10.7B USD | 67 | 78 | |
| 449 | 12.3B TWD (≈$381M) | 67 | 67 | |
| 450 | 31.0B THB (≈$867M) | 67 | 67 | |
| 451 | 4.0B USD | 67 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score